Twisting and Ironing: Doxorubicin Cardiotoxicity by Mitochondrial DNA Damage

被引：51
作者：
Nitiss, Karin C. [1 ,2 ]
Nitiss, John L. [1 ,2 ]
机构：
[1] UIC Coll Med, Dept Biomed Sci, Rockford, IL USA
[2] UIC Coll Pharm, Dept Biopharmaceut Sci, Rockford, IL USA
来源：
CLINICAL CANCER RESEARCH | 2014年 / 20卷 / 18期
关键词：
TOPOISOMERASE-I;
D O I：
10.1158/1078-0432.CCR-14-0821
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Anthracyclines are active clinical agents that have multiple mechanisms of cytotoxicity. Cardiotoxicity by anthracyclines limits the therapeutic potential of these agents, but mechanisms leading to cardiotoxicity remain controversial. Transgenic mice that lack mitochondrial topoisomerase I are hypersensitive to doxorubicin cardiotoxicity, providing support for cardiotoxicity arising from damage of mitochondrial DNA. (C)2014 AACR.
引用
收藏
页码：4737 / 4739
页数：3
相关论文
共 12 条
  • [1] Doroshow JH, 2012, CURR PHARM BIOTECHNO, V13, P1949
  • [2] Mitochondrial Topoisomerase I is Critical for Mitochondrial Integrity and Cellular Energy Metabolism
    Douarre, Celine
    Sourbier, Carole
    Dalla Rosa, Ilaria
    Das, Benu Brata
    Redon, Christophe E.
    Zhang, Hongliang
    Neckers, Len
    Pommier, Yves
    [J]. PLOS ONE, 2012, 7 (07):
  • [3] The role of iron in anthracycline cardiotoxicity
    Gammella, Elena
    Maccarinelli, Federica
    Buratti, Paolo
    Recalcati, Stefania
    Cairo, Gaetano
    [J]. FRONTIERS IN PHARMACOLOGY, 2014, 5
  • [4] Mitochondrial Topoisomerase I (Top1mt) Is a Novel Limiting Factor of Doxorubicin Cardiotoxicity
    Khiati, Salim
    Rosa, Ilaria Dalla
    Sourbier, Carole
    Ma, Xuefei
    Rao, V. Ashutosh
    Neckers, Leonard M.
    Zhang, Hongliang
    Pommier, Yves
    [J]. CLINICAL CANCER RESEARCH, 2014, 20 (18) : 4873 - 4881
  • [5] Mice lacking mitochondrial ferritin are more sensitive to doxorubicin-mediated cardiotoxicity
    Maccarinelli, Federica
    Gammella, Elena
    Asperti, Michela
    Regoni, Maria
    Biasiotto, Giorgio
    Turco, Emilia
    Altruda, Fiorella
    Lonardi, Silvia
    Cornaghi, Laura
    Donetti, Elena
    Recalcati, Stefania
    Poli, Maura
    Finazzi, Dario
    Arosio, Paolo
    Cairo, Gaetano
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 2014, 92 (08): : 859 - 869
  • [6] Targeting DNA topoisomerase II in cancer chemotherapy
    Nitiss, John L.
    [J]. NATURE REVIEWS CANCER, 2009, 9 (05) : 338 - 350
  • [7] Negative regulation of mitochondrial transcription by mitochondrial topoisomerase I
    Sobek, Stefan
    Dalla Rosa, Ilaria
    Pommier, Yves
    Bornholz, Beatrice
    Kalfalah, Faiza
    Zhang, Hongliang
    Wiesner, Rudolf J.
    von Kleist-Retzow, Juergen-Christoph
    Hillebrand, Frank
    Schaal, Heiner
    Mielke, Christian
    Christensen, Morten O.
    Boege, Fritz
    [J]. NUCLEIC ACIDS RESEARCH, 2013, 41 (21) : 9848 - 9857
  • [8] Oxidative Stress, Redox Signaling, and Metal Chelation in Anthracycline Cardiotoxicity and Pharmacological Cardioprotection
    Sterba, Martin
    Popelova, Olga
    Vavrova, Anna
    Jirkovsky, Eduard
    Kovarikova, Petra
    Gersl, Vladimir
    Simunek, Tomas
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2013, 18 (08) : 899 - 929
  • [9] Topoisomerase 2β: A Promising Molecular Target for Primary Prevention of Anthracycline-Induced Cardiotoxicity
    Vejpongsa, P.
    Yeh, E. T. H.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 (01) : 45 - 52
  • [10] Adriamycin-induced interference with cardiac mitochondrial calcium homeostasis
    Wallace, Kendall B.
    [J]. CARDIOVASCULAR TOXICOLOGY, 2007, 7 (02) : 101 - 107
12